Medications
A Fizzy Tablet Might One Day Replace a GLP-1 Shot
A new patent covers a fizzy tablet meant to carry GLP-1 medicine past your stomach. See how it would work and how early it really is.
Medications
How each GLP-1 works, what the doses mean, and how pills, pens and vials differ.
Medications
GLP-1 Pills Win on Convenience. Shots Still Lead on Weight Loss.
Oral GLP-1s are taking real market share. See the weight loss numbers side by side and where a pill or a shot genuinely fits better.
Medications
GLP-1s Are Now Most Obesity Care for Teens: What to Ask
GLP-1s are now 96% of obesity treatment for ages 13 to 25. See which are approved for teens, which are not, and what to ask a pediatrician.
Medications
Split Dosing a GLP-1: Two Shots a Week Instead of One
Some people split a weekly GLP-1 into two injections. See why, what the pharmacology suggests, the dosing risk, and what to ask your prescriber.
Medications
Gallbladder Problems on GLP-1s: Why They Happen and the Warning Signs
GLP-1 medicines slightly raise gallstone and gallbladder risk from fast weight loss. See how common it is, how to lower risk, and warning signs.
Medications
Wegovy Pill Hits 3 Million Scripts: Is $149 a Good Deal?
The Wegovy Pill passed 3 million prescriptions. What $149 self-pay covers, what the 25 mg dose costs, and how the pill compares to the shot.
More in Medications
- Medications
Additives in Compounded GLP-1s: What They Do and Allergy Risks
B12, B6, niacinamide, glycine, benzyl alcohol: see what each GLP-1 additive does, the allergy risks, and how to search providers by additive.
- Medications
GLP-1s in Summer: Heat, Hydration, and Storage Tips
Staying on a GLP-1 this summer? See how to avoid dehydration, store your pen below 86°F, travel safely, and what's true about sun sensitivity.
- Medications
GLP-1 Coverage Dropped Mid-Year? What You Can Do Next
Insurers and employers are cutting GLP-1 coverage mid-year. See why, how to tell if your plan changed, cash-pay options from $299, and how to appeal.
- Medications
CagriSema and the October 2026 FDA Decision: What to Know
CagriSema is under FDA review with a decision expected in 2026. See what the trials showed and how it compares to Wegovy and Zepbound.
- Medications
PCOS and GLP-1s: What the Research Shows and Its Limits
What the research shows about GLP-1 medications for PCOS, including weight, testosterone, periods, and why it is still an off-label use.
- Medications
Medicare GLP-1 Bridge: Your Step-by-Step July 1 Guide
The Medicare GLP-1 Bridge starts July 1, 2026. See who qualifies, which drugs cost $50, and how the prior authorization works step by step.
